Matrix removal of labyrinthine fistulae by non-suction technique with intraoperative dexamethasone injection.

about

Surgery for Cholesteatomatous Labyrinthine Fistula.Lateral semicircular canal fistula in cholesteatoma: diagnosis and management.Management of labyrinthine fistula: hearing preservation versus prevention of residual disease.

P2860

Q39029835-0554F30F-23E7-4DC5-9EF8-3EB59DB0CC10 Q40560944-F6EE6A62-A53F-4555-8825-86E46746F1DE Q41456474-CACEDFD1-4377-48E9-9B64-EF4016C5A804

P2860

Matrix removal of labyrinthine fistulae by non-suction technique with intraoperative dexamethasone injection.

Item

http://www.wikidata.org/entity/Q38117658

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Matrix removal of labyrinthine ...... ative dexamethasone injection.

@en

type

Item

label

Matrix removal of labyrinthine ...... ative dexamethasone injection.

@en

prefLabel

Matrix removal of labyrinthine ...... ative dexamethasone injection.

@en

P1476

Matrix removal of labyrinthine ...... rative dexamethasone injection

@en

P2093

Si Young Jo

http://www.w3.org/2001/XMLSchema#string

Yong Beom Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic indicators of hearing after complete resection of cholesteatoma causing a labyrinthine fistula.

Treatment of labyrinthine fistula with interruption of the semicircular canals.

Transection of the posterior ampullary nerve for the relief of benign paroxysmal positional vertigo.

Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging investigation of inner ear disturbances in cases of middle ear cholesteatoma with labyrinthine fistula.

Dexamethasone protects organ of corti explants against tumor necrosis factor-alpha-induced loss of auditory hair cells and alters the expression levels of apoptosis-related genes.

Risk factors for deterioration of bone conduction hearing in cases of labyrinthine fistula caused by middle ear cholesteatoma.

Preserving bone conduction in patients with labyrinthine fistula.

Conservation of hearing and protection of auditory hair cells against trauma-induced losses by local dexamethasone therapy: molecular and genetic mechanisms.

Surgical treatment of labyrinthine fistula in patients with cholesteatoma.

Surgical treatment of labyrinthine fistula in cholesteatoma surgery.

P304

910-915

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/00016489.2013.782105

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

133

http://www.w3.org/2001/XMLSchema#string

P50

Chul Ho Jang

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23808685

http://www.w3.org/2001/XMLSchema#string

P921

dexamethasone

Matrix removal of labyrinthine fistulae by non-suction technique with intraoperative dexamethasone injection.

about

P2860

P2860

Matrix removal of labyrinthine fistulae by non-suction technique with intraoperative dexamethasone injection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921